Elenius K - Search Results

1

Iivanainen E, Kähäri VM, Heino J, Elenius K. Iivanainen E, et al. Among authors: elenius k. Microsc Res Tech. 2003 Jan 1;60(1):13-22. doi: 10.1002/jemt.10238. Microsc Res Tech. 2003. PMID: 12500256 Review.

2

Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha.

Kainulainen V, Nelimarkka L, Järveläinen H, Laato M, Jalkanen M, Elenius K. Kainulainen V, et al. Among authors: elenius k. J Biol Chem. 1996 Aug 2;271(31):18759-66. doi: 10.1074/jbc.271.31.18759. J Biol Chem. 1996. PMID: 8702532 Free article.

3

Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells.

Nelimarkka L, Kainulainen V, Schönherr E, Moisander S, Jortikka M, Lammi M, Elenius K, Jalkanen M, Järveläinen H. Nelimarkka L, et al. Among authors: elenius k. J Biol Chem. 1997 May 9;272(19):12730-7. doi: 10.1074/jbc.272.19.12730. J Biol Chem. 1997. PMID: 9139731 Free article.

4

Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor.

Iivanainen E, Nelimarkka L, Elenius V, Heikkinen SM, Junttila TT, Sihombing L, Sundvall M, Maatta JA, Laine VJ, Yla-Herttuala S, Higashiyama S, Alitalo K, Elenius K. Iivanainen E, et al. Among authors: elenius k, elenius v. FASEB J. 2003 Sep;17(12):1609-21. doi: 10.1096/fj.02-0939com. FASEB J. 2003. PMID: 12958167

5

Intra- and extracellular signaling by endothelial neuregulin-1.

Iivanainen E, Paatero I, Heikkinen SM, Junttila TT, Cao R, Klint P, Jaakkola PM, Cao Y, Elenius K. Iivanainen E, et al. Among authors: elenius k. Exp Cell Res. 2007 Aug 1;313(13):2896-909. doi: 10.1016/j.yexcr.2007.03.042. Epub 2007 Apr 18. Exp Cell Res. 2007. PMID: 17499242

6

Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient.

Ihalainen S, Soliymani R, Iivanainen E, Mykkänen K, Sainio A, Pöyhönen M, Elenius K, Järveläinen H, Viitanen M, Kalimo H, Baumann M. Ihalainen S, et al. Among authors: elenius k. Mol Med. 2007 May-Jun;13(5-6):305-14. doi: 10.2119/2006–00069.Ihalainen. Mol Med. 2007. PMID: 17622327 Free PMC article.

7

ErbB targeted drugs and angiogenesis.

Iivanainen E, Elenius K. Iivanainen E, et al. Among authors: elenius k. Curr Vasc Pharmacol. 2010 May;8(3):421-31. doi: 10.2174/157016110791112241. Curr Vasc Pharmacol. 2010. PMID: 19485914 Review.

8

The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.

Iivanainen E, Lauttia S, Zhang N, Tvorogov D, Kulmala J, Grenman R, Salven P, Elenius K. Iivanainen E, et al. Among authors: elenius k. Microvasc Res. 2009 Dec;78(3):278-85. doi: 10.1016/j.mvr.2009.06.010. Epub 2009 Jul 9. Microvasc Res. 2009. PMID: 19596357

9

Neurite growth-promoting protein (amphoterin, p30) binds syndecan.

Salmivirta M, Rauvala H, Elenius K, Jalkanen M. Salmivirta M, et al. Among authors: elenius k. Exp Cell Res. 1992 Jun;200(2):444-51. doi: 10.1016/0014-4827(92)90194-d. Exp Cell Res. 1992. PMID: 1369684

10

Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization.

Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. Korhonen J, et al. Among authors: elenius k. Blood. 1992 Nov 15;80(10):2548-55. Blood. 1992. PMID: 1384789 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page